The adenosine A 2A receptor and the dopamine D 2 receptor are prototypically coupled to G s and G i /G o , respectively. In striatal intermediate spiny neurons, these receptors are colocalized in dendritic spines and act as mutual antagonists. This antagonism has been proposed to occur at the level of the receptors or of receptor-G protein coupling. We tested this model in PC12 cells which endogenously express A 2A receptors. The human D 2 receptor was introduced into PC12 cells by stable transfection. A 2A -agonistmediated inhibition of D 2 agonist binding was absent in PC12 cell membranes but present in HEK293 cells transfected as a control. However, in the resulting PC12 cell lines, the action of the D 2 agonist quinpirole depended on the expression level of the D 2 receptor: at low and high receptor levels, the A 2A -agonist-induced elevation of cAMP was enhanced and inhibited, respectively. Forskolin-stimulated cAMP formation was invariably inhibited by quinpirole. The effects of quinpirole were abolished by pretreatment with pertussis toxin. A 2A -receptor-mediated cAMP formation was inhibited by other G i /G o -coupled receptors that were either endogenously present (P 2y12 -like receptor for ADP) or stably expressed after transfection (A 1 adenosine, metabotropic glutamate receptor-7A). Similarly, voltage activated Ca 2+ channels were inhibited by the endogenous P 2Y receptor and by the heterologously expressed A 1 receptor but not by the D 2 receptor. These data indicate functional segregation of signaling components. Our observations are thus compatible with the proposed model that D 2 and A 2A receptors are closely associated, but they highlight the fact that this interaction can also support synergism.
INTRODUCTION
In the central nervous system, adenosine and dopamine act as neuromodulators that bind to G-protein-coupled receptors and impinge on fast synaptic transmission by inhibitory and excitatory amino acids. Both the G s /G olfcoupled A 2A adenosine receptor and the G i /G o -coupled D 2 dopamine receptor are enriched in the corpus striatum and in mesolimbic areas, such as the nucleus accumbens and the lateral septum . In these brain regions, the two receptors are mostly colocalized, and various types of interactions between A 2A and D 2 receptor ligands reveal a functional link between these two proteins: (i) Blockage of D 2 receptors (eg by neuroleptic drugs or by targeted knockout of the gene) or depletion of dopamine impairs locomotion, and this dysfunction can be ameliorated by the administration of A 2A antagonists (see Aoyama et al, 2000; Grondin et al, 1999 ; earlier references in Richardson et al, 1997) . (ii) Activation of A 2A receptors induces catalepsy (Ferré et al, 1991a) as do D 2 antagonists. Conversely, catalepsy induced by blockage of D 2 receptors is reversed by A 2A antagonists (Hauber et al, 2001) . (iii) The induction of the immediate-early gene c-fos by D 2 antagonists is attenuated by blockage of A 2A receptors; this effect is confined to neurons where the receptors are coexpressed (Pinna et al, 1999) . Taken together, these results indicate that there is a functional antagonism between A 2A and D 2 receptors (Ferré et al, 1997) . In line with these experimental data, both retrospective epidemiological evidence Benedetti et al, 2000 and references therein) as well as prospective cohort studies (Ross et al, 2000; Ascherio et al, 2001) indicate that blockage of A 2A receptors by caffeine intake reduces the risk of people to develop Parkinson's disease. Similarly, the adenosine uptake inhibitor dipyridamol enhances the antipsychotic activity of the D 2 antagonist haloperidol (Akhondzadeh et al, 2000) . Thus, A 2A receptor ligands have been recognized as novel therapeutic agents for illnesses typically treated with D 2 receptor ligands.
The functional antagonism between D 2 and A 2A receptors has been proposed to reflect the ability of the A 2A receptor to impair high-affinity agonist binding to the D 2 receptor by a membrane-delimited process. This effect was originally observed in rat striatal membranes (Ferré et al, 1991b) , and subsequently also documented upon heterologous expression of the receptors in fibroblast cell lines (Ltk-murine fibroblasts in Dasgupta et al, 1996 ; Chinese hamster ovary cells in Kull et al, 1999) . Agonist occupancy of the A 2A receptor blunted high-affinity agonist binding to the D 2 receptor in the absence of GTP; hence, the effect was proposed to be accounted for by an interaction at the level of the receptors or of receptor-G protein complexes. While this model explains the antagonistic action of the A 2A adenosine receptor, several observations, however, cannot be accounted for by simple reciprocal antagonism at the level of these two receptors. Most importantly, mice lacking A 2A receptors display a hypodopaminergic phenotype (Dassesse et al, 2001) ; similarly, stimulation of the striatal A 2A receptor fails to elevate cAMP in mice that are deficient in D 2 receptors (Zahniser et al, 2000) . These findings may reflect adaptive changes that occur during development to cope with the targeted deletion of the respective genes. Alternatively, they may indicate that the interaction between the A 2A receptor and the D 2 receptor is not solely mutually antagonistic. In the present work, we employed the neuroendocrine cell line PC12 to examine effector regulation by the combined stimulation of the A 2A adenosine and D 2 dopamine receptor. PC12 cells can be differentiated into a neuronal phenotype by nerve growth factor. Our results demonstrate that D 2 receptors can synergize with A 2A receptors to stimulate cAMP accumulation, a property that is not shared by other G i /G o -coupled receptors. 0 -N-ethylcarboxamidoadenosine) from Tocris (Bristol, UK). Affinity-purified rabbit antiserum against rap1/Krev-1 was from Santa Cruz Biotechnology (Santa Cruz, CA). Immunofluorescence was performed with anti-c-myc antibody (Santa Cruz Biotechnology), anti-FLAG antibody M2 (Stratagene, La Jolla, CA), anti-HA antibody 16B12 (kind gift of E Ogris, Vienna Biocenter), Cy3-coupled goat anti-rabbit (Amersham, Buckinghamshire, UK), and FITC-coupled goat anti-mouse (Jackson, West Grove, PA).
MATERIAL AND METHODS

Materials
Cell Culture and Transfection
PC12 cells were plated onto collagen-coated culture dishes (Biomedical Technologies Inc., Stoughton, MA, USA), propagated in Opti-Mem medium containing 10% (vol/ vol) horse serum, 5% (vol/vol) FCS, 0.2 mM L-glutamine, 25 000 U/l penicillin G, and 25 mg/l streptomycin. Media for culture of stably transfected cells were supplemented with 0.2 mg/ml geneticin (G418) in order to maintain the selection pressure. Transfection of PC12 cells and of HEK293 was performed using lipofection (TransFast s , Promega, Madison, WI) and CaPO 4 -precipitation, respectively. The plasmids employed encoded the wild type and epitope-tagged versions of the human D 2 dopamine (BofillCardona et al, 2000) , the FLAG-tagged metabotropic glutamate receptor-7A (mGluR7A) (ElFar et al, 2001) , the c-myc-tagged human A 2A adenosine receptor (Klinger et al, 2002) , and the HA-tagged A 1 adenosine receptor; the latter was generated by PCR using a primer that extended the Nterminus by the nine amino acids (YPYDVPDYA) that represent the major epitope of influenza hemaglutinin. The integrity of the coding sequence was verified by fluorescent sequencing. After 48 h, geneticin (G418; 0.8 mg/ml) was added to the media to initiate selection for stably transfected cells. 
Prior to the recording of I Ca , PC12 cells were detached from culture dishes and replated at low density. In order to induce neuronal differentiation, PC12 cells were exposed to recombinant human NGF (50 ng/ml) for 5-6 days.
Membrane Preparation and Receptor Binding
Cells were harvested and membranes were prepared as previously described (Waldhoer et al, 1998) . The final membrane pellet was resuspended in buffer (25 mM Hepes.NaOH, pH 7.5, 1 mM EDTA, 2 mM MgCl 2 ) at a protein concentration of 8-10 mg/ml and stored in aliquots at À801C. Binding of [ 
Accumulation of cAMP
The adenine nucleotide pool of PC12 cells was metabolically prelabeled for 16 h with [
3 H]adenine (1 mCi/well) in Optimem containing 1% (vol/vol) horse serum and 1 U/ml adenosine deaminase as outlined previously (Kudlacek et al, 2001) . After the preincubation, fresh medium was added that contained adenosine deaminase (1 U/ml) and 100 mM RO201724; 30 min later, cAMP formation was stimulated by the A 2A selective agonist CGS21680 (1 mM, if not otherwise indicated) or by 25 mM forskolin for 15 min in the absence and presence of agonists for the G i /G o -coupled receptors (quinpirole, ADPbS, ADP, CPA, L-AP4; see figures for concentrations). Assays were performed in triplicate. The formation of [ 3 H]cAMP was determined according to Salomon (1991) .
Pull-Down Assay for the Determination of Rap1-Activation
The GST fusion protein comprising the rap1-binding domain of ralGDS (ral-RBD, Franke et al, 1997) was expressed in E. coli (strain BL21DE3) and used to trap GTP-loaded rap1 as described (Seidel et al, 1999) . Cells were prepared for the assay in a similar way as for accumulation of cAMP (serum withdrawal for 16 h in the presence of adenosine deaminase followed by replacement by fresh medium containing adenosine deaminase). Subsequently cells were incubated with CGS21680 or vehicle for 5 min. The amount of recovered GTP-liganded rap1 was quantified by scanning immunoblots using a BioRad GelDoc1000 and Molecular Analyst software.
Electrophysiology
Voltage-activated Ca 2+ currents were determined as described before (Vartian and Boehm, 2001 ). Prior to the recording of I Ca , PC12 cells were detached from culture dishes and replated at low density. Whole-cell currents were recorded at room temperature (20-241C) from PC12 cells 24-48 h after replating at low density, using an Axopatch 200B amplifier and the Pclamp 6.0 hard-and software (Axon Instruments, Foster City, CA, USA). Currents were low-pass filtered at 5 kHz, digitized at 50 kHz, and stored on an IBM-compatible computer. Traces were analyzed off-line by the Clampfit program (Axon). Patch electrodes were pulled (Flaming-Brown puller, Sutter Instruments, Novato, CA, USA) from borosilicate glass capillaries (Science Products, Frankfurt/Main, Germany) and filled with a solution consisting of (mM) CsCl (130), tetraethylammonium chloride (20), CaCl 2 (0.24), glucose (10), HEPES (10), EGTA (5), Mg-ATP (2), and Li-GTP (2), adjusted to pH 7.3 with KOH, to yield tip resistances of 2-3 MO. The external bathing solution consisted of (mM) NaCl (120), tetraethylammonium chloride (20), KCl (3), MgCl 2 (2), CaCl 2 (5), glucose (20), HEPES (10), adjusted to pH 7.3 with KOH. Drugs were applied via a DAD-12 drug application device (Adams & List, Westbury, NY, USA), which permits a complete exchange of solutions surrounding the cells under investigation within less than 100 ms (see Vartian and Boehm, 2001) . To evaluate the effects of receptor agonists, PC12 cells were exposed to these agents for at least 30 s. Unless otherwise indicated, whole-cell Ca 2+ currents were elicited by 30 ms depolarizations from a holding potential of À80 mV to 0 mV at a frequency of 4 min À1 . I Ca was quantified by measuring peak current amplitudes during the depolarization to 0 mV. To account for timedependent changes in Ca 2+ current amplitudes, drug effects were evaluated by evoking currents in the presence of test drugs (B) and by comparing them to control currents recorded before (A) and after (washout, C) the application of the drugs, according to the equations: Vartian and Boehm, 2001) . Significance of differences between single data points was evaluted by the MannWhitney test.
If not otherwise indicated, all experiments were carried out at least three times and means 7 SD are reported.
RESULTS
Heterologous Expression of G Protein-Coupled Receptors in PC12 Cells
The rat pheochromocytoma cell line PC12 can be differentiated to adopt a neuron-like phenotype. In addition, PC12 cells endogenously express A 2A adenosine receptors. We therefore used this cell line as a model system to study the interaction of A 2A and D 2 receptors. The latter was introduced by stable transfection (PC12-D 2 ), because we were unable to detect appreciable levels of D 2 receptors in PC12 cell lines from two different sources (data not shown). After stable transfection, cell clones were isolated that expressed D 2 receptors at levels ranging from 20 to 1500 fmol/mg. A representative saturation experiment is shown in Figure 1a , where membranes from a clone that expressed 60 fmol/mg were incubated with the high-affinity 125 I]epidepride in striatal membranes (120-160 fmol/mg; Beindl et al, 1996) . The expression level of the endogenous A 2a adenosine receptor in these cells was determined with an A 2A -selective antagonist; a B max of 1.6 7 0.2 pmol/mg was estimated from saturation isotherms for the binding of In order to carry out control experiments (see below), two additional G i/o -coupled receptors, namely the A 1 adenosine receptor and the mGluR7A, were expressed in PC 12 cells and stable cell lines were generated. The expression level of the A 1 adenosine receptor was determined by binding of the high-affinity A 1 agonist [ 3 H]CCPA to membranes of PC12 cells; a cell clone was selected that expressed about 1 pmol/ mg ( Figure 1b) ; that is, the membrane levels of this receptor was within the range at which this receptor is typically expressed in brain membranes of most species, including man (Jockers et al, 1994) . Cell lines were also generated that expressed the group III mGluR7A. A suitable radioligand is not available for this receptor. Hence, the expression of this receptor was monitored by staining the cells for membraneassociated immunoreactivity. The rationale for employing mGluR7A is the fact that this receptor is specifically targeted to presynaptic specializations (Shigemoto et al, 1996; Stowell and Craig, 1999) . Hence, the use of mGluR7A allowed to gauge the capacity of PC12 cells to support a spatial segregation of a receptor by sorting and targeting. Upon NGF-induced differentiation of PC12 cells, mGluR7A was indeed delivered to the tips of the extending neurites (data not shown). (Ferré et al, 1991b) , Ltk-murine fibroblasts (Dasgupta et al, 1996) , and Chinese hamster ovary (CHO) cells . We therefore tested the effects of the A 2A agonist CGS21680 on the binding of the D 2 agonist [ 125 I]OH-PIPAT bound with high affinity to about 40% of the D 2 dopamine receptors (B max ¼ 26 7 5 ffmol/mg) that were labeled by the antagonist (cf Figure 1a) . Addition of CGS 21680 (closed circles in Figure 2a ) did not affect the B max or the K D (0.65 7 0.13 and 0.59 7 0.11 nM in the absence and presence of CGS21680, respectively) for binding of [ 125 I]OH-PIPAT. These findings differ from the observations reported for transfected fibroblast cell lines (Dasgupta et al, 1996; Kull et al, 1999) , where the A 2A agonist impedes ternary complex formation by the agonistliganded D 2 receptor. We therefore also expressed the A 2A adenosine receptor and D 2 dopamine receptor in HEK293 cells, a human fibroblast line. As can be seen from Figure 2c (Dasgupta et al, 1996; Kull et al, 1999 . In the clones employed in the present work, the A 2A agonist CGS21680 gave a robust stimulation of cAMP levels (E max ¼ B4-8-fold over basal levels; EC 50 ¼ 25-50 nM; see Figure 4c ). Activation of the D 2 dopamine receptor was expected to inhibit adenylyl cyclase via G i /G odependent signaling and to thereby blunt the stimulatory action of the A 2A agonist. However, if the D 2 agonist quinpirole was added to PC12 cells that expressed D 2 receptors at B60 fmol/mg in the presence of a saturating concentration of CGS21680 (1 mM), the level of cAMP was further augmented by about 30% (circles in Figure 3a) . The EC 50 of quinpirole for this effect was 4.0 7 1.2 nM. This potentiation was also seen with a second (independent, stably transfected) cell clone that expressed lower levels of D 2 receptor (20 fmol/mg, closed squares in Figure 3b) ; conversely, quinpirole did not elicit any effect on PC12 cells that did not express the D 2 dopamine receptor (not shown). Alternatively, cAMP accumulation was triggered by direct activation of adenylyl cyclase in the presence of 25 mM forskolin; this concentration resulted in cAMP levels that were reasonably similar to those triggered by saturating CGS21680 (see Figure 4a and b and Kudlacek et al, 2001) . Addition of quinpirole inhibited the forskolin-stimulated Figure 3a ; open squares in Figure 3b ). The EC 50 (8.7 7 4.6 nM) was in the same range as that for the stimulating effect. PC12 cells were pretreated with pertussis toxin to block signaling via G i /G o . This pretreatment abolished both the ability of quinpirole to enhance cAMP formation in the presence of A 2A agonist CGS21680 (squares in Figure 3a ) and to reduce forskolinstimulated cAMP accumulation (diamonds in Figure 3a) .
Effect of the
We also examined additional stably transfected PC12 cell clones that expressed higher levels of D 2 receptors, namely B100 and 300 fmol/mg (as assessed by binding of [ 125 I]epidepride). In PC12 cells carrying higher receptor levels, quinpirole inhibited A 2A agonist (closed circles and triangles in Figure 3b ) and forskolin-stimulated cAMP accumlation to a roughly equivalent extent (open circles and triangles in Figure 3b ). Finally, we also measured the effect of a quinpirole on A 2A -agonist-induced cAMP formation in HEK293 cells, in which the level of D 2 receptor expression was reasonably comparable to that seen in PC12 cells (cf Figure 2a and c) . In HEK293 cells, stimulation of the D 2 dopamine receptor invariably caused inhibition of A 2A -receptor-induced cAMP accumulation. The transfection of HEK293 cells was only transient. However, the transfection efficiency was high (ie substantially 450%); this is also evident from the observation that forskolin-stimulated cAMP accumulation was inhibited by about 75% (righthand bars in Figure 2d) .
Inhibition of cAMP accumulation is the expected response to D 2 dopamine receptors. In the PC12 cell clone that expressed B60 fmol/mg D 2 receptors, we have there- H]adenine (1 mCi/ml) was added to metabolically label the adenine nucleotide pool; thereafter, the cells were preincubated for 30 min with RO201724 (100 mM) and adenosine deaminase (1 U/ml) and subsequently stimulated for 15 min with 1 mM CGS21680 (circles and squares) or 25 mM forskolin (triangles and diamonds) and the indicated concentrations of quinpirole. Data are means 7 SD from three independent experiments that were performed in triplicate and carried out in parallel. (c) PC12 cells were rendered quiescent by serum withdrawal for 16 h in the presence of adenosine deaminase (1 U/ml); 30 min after the addition of fresh medium containing adenosine deaminase (ADA), the cells received vehicle (lane ADA) or were stimulated by 1 mM CGS21680 (CGS), 10 nM quinpirole, or the combination of CGS21680 and quinpirole. GTP-liganded rap1 was trapped by the addition of a fusion protein comprising GST and the rap-binding domain of ral(GDS); 30% aliquots of the material recovered in the pull-down assay were applied to an SDS-polyacrylamide gel, transferred to nitrocellulose and immunoblotted for rap1; in the lane labeled lysate an appropriate amount of the detergent lysate from unstimulated cells was applied to the gel. The bar diagram summarizes the densitometric quantitation (n ¼ 3); error bars indicate SD; *po0.05 quinpirole+CGS21680 vs CGS21680 (Student's t-test).
Synergistic interaction of A 2A -and D 2 -receptor O Kudlacek et al
fore employed an additional approach to obtain independent evidence for enhanced cAMP accumulation. This relied on Epac-induced activation of rap1. Epac, the guanine nucleotide exchange factor of the small G protein rap1, is directly controlled by cAMP (de Rooij et al, 1998) ; raising cellular cAMP levels thus leads to exchange of GTP for GDP on rap1 and the resulting GTP-liganded rap1 can be trappedFafter cell lysisFby using the Rap-binding domain (RBD) of RalGDS as a bait (Franke et al, 1997) . As expected, CGS21680 stimulated the accumulation of GTP-loaded rap1 (Figure 3c ). In contrast, quinpirole per se did not have any appreciable effect (cf control lane ADA with lane quinpirole in Figure 3c ). However, if PC12 cells were challenged with both CGS21680 and quinpirole, GTPbound rap1 accumulated to levels that significantly exceeded (po0.05, Student's t-test) those seen in the presence of CGS21680 alone (Figure 3c and d) . Thus, the synergistic stimulation induced by the D 2 agonist resulted in accumulation of cAMP over a range that was physiologically relevant because it was sensed by an intracellular cAMP-binding effector, namely Epac (de Rooij et al, 1998) .
Inhibition of cAMP Formation by other G i /G o -Coupled Receptors in PC12 Cells
With the exception of the type IX isoform, all membranebound forms of mammalian adenylyl cyclase are activated by forskolin, albeit to a variable extent (Sunahara et al, 1996; Hanoune and Defer, 2001 ger et al, 2002) . In both, the untransfected parent PC12 cells (Figure 4a ) as well as in the PC12 cell lines stably expressing the D 2 receptor (not shown), the physiological agonist ADP and ADPbS, an analog that is more resistant to metabolism (phosphorylation to ATP and dephosphorylation to AMP), inhibited the cAMP accumulation induced by CGS21680 with a potency in the submicromolar range. Forskolinstimulated activity was inhibited over a similar concentration range of ADPbS and with similar efficacy, that is, by about 40-50%. The discrepancy between the P2y receptor and the D 2 receptor may have arisen from the difference between endogenous and heterologous expression. We have therefore also checked if the A 2A -receptor-dependent cAMP accumulation was enhanced or inhibited by two additional, heterologously expressed G i /G o -coupled receptors, namely the A 1 adenosine receptor and the mGluR7A. In stably transfected PC12 cells endowed with mGluR7A, the A 2A adenosine receptor-and forskolin-induced cAMP formation was inhibited by the group III-specific metabotropic glutamate receptor agonist L-AP4 (Figure 4b ). While the effect was seen over a similar concentration range, the inhibition of forskolin-stimulated cAMP accumulation was more pronounced than that induced by activation of the A 2A adenosine receptor (Figure 4b) . Similarly, in PC12 cells expressing the A 1 receptor at levels compatible with the endogenous expression in the CNS (B1 pmol/mg, see Figure 1b ), the A 1 agonist CPA employed at the A 1 -selective concentration of 20 nM blunted the stimulatory effect of the A 2A agonist CGS21680 by about 30-40%; this inhibition was also seen with R-PIA, another A 1 -selective agonist, and was uniform over the entire concentration-response curve for CGS21680 (Figure 4c) . As expected, A 1 -selective agonists displayed biphasic concentration-response curves when tested in the presence of forskolin, namely an A 1 -receptormediated inhibition of cAMP formation at low concentrations (by about 50%) (data not shown) and an A 2A adenosine receptor-dependent stimulation at high concentrations (not shown).
Effects of G i/ G o -Coupled Receptors on Voltage-Activated Ca 2+ Currents in PC12 Cells
In neuroendocrine cells G i/ G o -coupled receptors inhibit voltage-activated Ca 2+ currents, an effect that can also be reproduced in both differentiated and undifferentiated PC12 cells (Vartian and Boehm, 2001 ). We therefore investigated if quinpirole inhibited Ca 2+ currents in PC12 cells that stably expressed the D 2 dopamine receptor. In these transfected cells, the P 2Y agonists ADP and ADPbS, which were employed as positive controls, decreased the Ca 2+ current by 50% (Figure 5a and b) . In contrast, quinpirole had little or no effect on the Ca 2+ current even when applied at the very high concentration of 10 mM (Figure 5a and b) . Again, we ruled out that this discrepancy between endogenously present P 2Y receptor and heterologously introduced D 2 receptor was accounted for by the forced expression; in PC12 cells that heterologously expressed the A 1 adenosine receptor, the receptor agonist CPA decreased the Ca 2+ current by 30%, an effect that was totally abolished by addition of the adenosine receptor antagonist XAC at 1 mM (Figure 6a and b) . XAC did not affect the ADP-mediated inhibition of Ca 2+ current in PC12 that carried A 1 adenosine receptors. Similarly, the effect of CPA was absent in cells that did not express the A 1 adenosine receptor (not shown). It is worth pointing out that the discrepancy between the A 1 adenosine receptor and the D 2 dopamine receptor can neither be accounted for by the low expression levels of the D 2 dopamine receptor nor by clonal variation. account for the mutual antagonism that can be observed in striatopallidal neurons (Lindskog et al, 1999) . This assumption is based on both observations in membranes prepared from the striatum (Ferré et al, 1991b) as well as from transfected cells (Dasgupta et al, 1996; Kull et al, 1999) (Yao et al, 2002) . Our observations also indicate that the expression level of the D 2 receptor is important in determining whether this receptor pair raises cAMP synergistically. Low levels of D 2 receptors favored coactivation while at higher expression levels the A 2A -induced cAMP response was inhibited. The concentration of D 2 receptors in PC12 cell membranes was within the range found in various brain areas; nevertheless, it is not possible to extrapolate these numbers and predict the response of D 2 receptor containing neurons because the local concentration at pre-or postsynaptic specializations is not known. Regardless of these limitations, the physiological relevance of our observations is underscored by the recent study of Yao et al (2002) ; this work also demonstrates that D 2 and A 2A receptors synergize to activate cAMP-dependent signaling in rat hippocampal neurons and in the nucleus accumbens. The synergism exerted in the latter region apparently supports sustained alcohol consumption (Yao et al, 2002) .
Synergistic stimulation of adenylyl cyclase activity is to be expected because most isoforms of adenylyl cyclase have the capacity to function as coincidence detectors (Sunahara et al, 1996; Hanoune and Defer, 2001) ; for example, adenylyl cyclase type-I and to a lesser extent type-VIII are synergistically activated by Ga s and Ca 2+ /calmodulin (Xia and Storm, 1997) . Similarly, the activation of adenylyl cyclase type-II, -IV, and -VII by Gbg is conditional on the presence of activated Ga s (Taussig et al, 1994) . In PC12 cells, the potentiating effect of the D 2 agonist (and its inhibitory action) was abrogated upon pretreatment of the cells with pertussis toxin. Thus both stimulation and inhibition depended on the presence of G i or G o . Most cells express several adenylyl cyclase isoforms (Hanoune and Defer, 2001) . This is true for PC12 cells where the type-VI enzyme is abundant but not the only isoform (Chern et al, 1995) . Adenylyl cyclase type-VI and -V are inhibited by Ca 2+ . In reconstitution experiments, they are also inhibited by Ga i subunits, but Gbg has no appreciable effect (Taussig et al, 1994; Kudlacek et al, 2001) . In contrast, D 2 -receptormediated stimulation was contingent on the formation of active Ga s by the A 2A adenosine receptor; forskolin-induced cAMP accumulation was invariably inhibited by the D 2 receptor. For a parsimonious explanation, the synergism is most readily accounted for by assuming that G protein subunits, that is, GTP-liganded Ga s generated by activation of the A 2A receptor and Gbg generated by activation of the D 2 receptor, converge at the level of adenylyl cyclase. Hence, the likely candidate mechanism that underlies the costimulatory action of the D 2 receptor is Gbg-dependent activation of a type-II-like adenylyl cyclase. In fact, protein fragments that scavenge free Gbg are capable of eliminating the synergism between D 2 and A 2A receptors in both NG108-15 cells and neurons (Yao et al, 2002) .
At low expression levels, D 2 receptors supported synergistic activation of A 2A -receptor-dependent cAMP accumulation; the effect was lost at higher expression levels and a robust inhibition was seen. This observation is consistent with the combined action on a type-II-and a type VI-like adenylyl cyclase isoform. The conditional activation of a type-II-like adenylyl cyclase requires concentrations of Gbg in the low nanomolar range (Taussig et al, 1993) . In contrast, inhibition of isoforms V and VI by activated Ga i requires concentrations that are about 10-fold higher (Taussig et al, 1994) . Thus Gbg generated at low D 2 receptor concentrations may suffice for sensitization of a type-II-like adenylyl cyclase, whereas at high receptor levels the amounts of active Ga i reach the threshold to support inhibition of the abundant type-VI enzyme in PC12 cells.
In the clones that express high receptor numbers, stimulation of cAMP accumulation was to be expected at low occupancy of the receptor by the D 2 agonist. In some experiments, this was indeed the case. However, it was not seen reproducibly. The limits of detection can be calculated by Monte Carlo simulation by using the parameters obtained at high and low receptor expression, that is, 1.3-fold maximum stimulation and maximum inhibition by 60-70%. The synthetic data were generated with a realistic random error of 5-10%. Under these assumptions, an initial stimulation was only detected reliably if EC 50 (for stimulation of cAMP accumulation) and IC 50 (for inhibition of cAMP accumulation) differed by 4100-fold (for an analogous analysis, see Freissmuth et al, 1987) . Thus, if receptor occupancy and effect were directly related, the expression levels would have to be increased 100-fold in order to detect the stimulation at low agonist concentrations (in the presence of the ensuing inhibition at higher receptor occupancy). In other words, inhibition would be reliably detected only if D 2 receptor expression levels were raised to 46 pmol/mg.
The synergism was restricted to the pair A 2A receptor/D 2 receptor and not seen if the endogenous P 2Y receptor or the transfected A 1 receptor and mGluR7A were activated. Obviously, the A 1 adenosine receptor was expressed at levels that far exceeded those at which synergism was seen with the D 2 dopamine receptor. Contrary to the D 2 receptor, mGluR7A only supported inhibition of cAMP formation. Similarly, when present at 1 pmol/mg, the A 1 receptor only inhibited A 2A -dependent cAMP accumulation by B50%. In contrast, when present at 0.3 pmol/mg, the D 2 receptor blunted the A 2A response by 70%. The most plausible explanation for these discrepancies is to assume that receptors (and effectors) are segregated rather than freely diffusible and that A 2A and D 2 receptors are closely associated. In fact, complexes of these two receptors have been observed that are sufficiently stable to allow for coimmunoprecipitation of D 2 receptors with A 2A receptors (Hillion et al, 2002) .
Taken together, our data are consistent with the concept that the D 2 receptor and the A 2A receptor form a unique pair when present within the membrane of a given cell (Ferré et al, 1991b; Dasgupta et al, 1996; Kull et al, 1999) . However, the interaction between these two receptors does not necessarily result in mutual antagonism. Finally, the emphasis on adenylyl cyclase regulation and on G protein coupling may detract from alternative signaling pathways. Although A 2A receptors do not raise cAMP levels in striata of mice that are deficient in D 2 receptors (Zahniser et al, 2000) , A 2A antagonists still partially restore locomotor activity in these animals. This indicates that neither changes in cAMP nor the presence of D 2 receptors are required to account for their beneficial effect on animal models of Parkinson's disease (Aoyama et al, 2000; Zahniser et al, 2000; Chen et al, 2001 ). In fact, the A 2A receptor has the capacity to signal in a manner independent of Ga s (Sexl et al, 1997; Seidel et al, 1999) .
